Debra Van Egeren

Dr. Debra Van Egeren

Stanford Cancer Institute, Stanford Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2014 in Nature
Verified
Journal Article
Closed access
PDF file
HLHaipeng Liu
Haipeng Liu
KMKelly D. Moynihan
Kelly D. Moynihan
YZYiran Zheng
Yiran Zheng
GSGregory L. Szeto
Gregory L. Szeto
ALAdrienne V. Li
Adrienne V. Li
DIDarrell J. Irvine
Darrell J. Irvine

22 May 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GSGregory Lee Szeto
Gregory Lee Szeto
DEDebra Van Egeren
Debra Van Egeren
HWHermoon Worku
Hermoon Worku
ASArmon Sharei
Armon Sharei
BABrian Alejandro
Brian Alejandro
DIDarrell J Irvine
Darrell J Irvine
B-cells are promising candidate autologous antigen-presenting cells (APCs) to prime antigen-specific T-cells both in vitro and in vivo. However to date, a significant barrier to utilizing B-cells as APCs is their low capacity for non-specific antigen uptake compared to “professional” APCs such as dendritic cells. Here we utilize a microfluidic device that employs many parallel channels to pass single cells through narrow constrictions in high throughput. This microscale “cell squeezing” process creates transient pores in the plasma membrane, enabling intracellular delivery of whole proteins from the surrounding medium into B-cells via mechano-poration. We demonstrate that both resting and activated B-cells process and present antigens delivered via mechano-poration exclusively to antigen-specific CD8+T-cells and not CD4+T-cells. Squeezed B-cells primed and expanded large numbers of effector CD8+T-cells in vitro that produced effector cytokines critical to cytolytic function, including granzyme B and interferon-γ. Finally, antigen-loaded B-cells were also able to prime antigen-specific CD8+T-cells in vivo when adoptively transferred into mice. Altogether, these data demonstrate crucial proof-of-concept for mechano-poration as an enabling technology for B-cell antigen loading, priming of antigen-specific CD8+T-cells and decoupling of antigen uptake from B-cell activation.

15 December 2021 in Experimental Hematology
Verified
Journal Article
Closed access
DEDebra Van Egeren
Debra Van Egeren
BKBaransel Kamaz
Baransel Kamaz
SLShichen Liu
Shichen Liu
MNMaximilian Nguyen
Maximilian Nguyen
CRChristopher R. Reilly
Christopher R. Reilly
SHSahand Hormoz
Sahand Hormoz

16 April 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
DEDebra Van Egeren
Debra Van Egeren
MSMadison Stoddard
Madison Stoddard
LWLaura F White
Laura F White
NHNatasha S. Hochberg
Natasha S. Hochberg
MRMichael S Rogers
Michael S Rogers
ACArijit Chakravarty
Arijit Chakravarty
The rapid emergence of immune-evading viral variants of SARS-CoV-2 calls into question the practicality of a vaccine-only public-health strategy for managing the ongoing COVID-19 pandemic. It has been suggested that widespread vaccination is necessary to prevent the emergence of future immune-evading mutants. Here, we examined that proposition using stochastic computational models of viral transmission and mutation. Specifically, we looked at the likelihood of emergence of immune escape variants requiring multiple mutations and the impact of vaccination on this process. Our results suggest that the transmission rate of intermediate SARS-CoV-2 mutants will impact the rate at which novel immune-evading variants appear. While vaccination can lower the rate at which new variants appear, other interventions that reduce transmission can also have the same effect. Crucially, relying solely on widespread and repeated vaccination (vaccinating the entire population multiple times a year) is not sufficient to prevent the emergence of novel immune-evading strains, if transmission rates remain high within the population. Thus, vaccines alone are incapable of slowing the pace of evolution of immune evasion, and vaccinal protection against severe and fatal outcomes for COVID-19 patients is therefore not assured.

25 November 2025 in Nature
Verified
Journal Article
Open access
PDF file
DEDebra Van Egeren
Debra Van Egeren
RSRyan O. Schenck
Ryan O. Schenck
AKAziz Khan
Aziz Khan
AHAaron M. Horning
Aaron M. Horning
SMShanlan Mo
Shanlan Mo
CCChristina Curtis
Christina Curtis
Cancer is generally thought to be caused by expansion of a single mutant cell1. However, analyses of early colorectal cancer lesions suggest that tumors may instead originate from multiple, genetically distinct cell populations2,3. Detecting polyclonal tumor initiation is challenging in patients, as it requires profiling early-stage lesions before clonal sweeps obscure diversity. To investigate this, we analyzed normal colorectal mucosa, benign and dysplastic premalignant polyps, and malignant adenocarcinomas (123 samples) from six individuals with familial adenomatous polyposis (FAP). Individuals with FAP have a germline heterozygous APC mutation, predisposing them to colorectal cancer and numerous premalignant polyps by early adulthood4. Whole-genome and/or whole-exome sequencing revealed that many premalignant polyps—40% with benign histology and 28% with dysplasia—were composed of multiple genetic lineages that diverged early, consistent with polyclonal origins. This conclusion was reinforced by whole-genome sequencing of single crypts from multiple polyps in additional patients which showed limited sharing of mutations among crypts within the same lesion. In some cases, multiple distinct APC mutations co-existed in different lineages of a single polyp, consistent with polyclonality. These findings reshape our understanding of early neoplastic events, demonstrating that tumor initiation can arise from the convergence of diverse mutant clones. They also suggest that cell-intrinsic growth advantages alone may not fully explain tumor initiation, highlighting the importance of microenvironmental and tissue-level factors in early cancer evolution.

26 September 2018 in Communications Biology
Verified
Journal Article
Open access
PDF file
DEDebra Van Egeren
Debra Van Egeren
TMThomas Madsen
Thomas Madsen
FMFranziska Michor
Franziska Michor
Individuals in a population often have different fitnesses even when they have identical genotypes, but the effect of this variation on the evolution of a population through complicated fitness landscapes is unknown. Here, we investigate how populations with non-genetic fitness variation cross fitness valleys, common barriers to adaptation in rugged fitness landscapes in which a population must pass through a deleterious intermediate to arrive at a final advantageous stage. We develop a stochastic computational model describing the dynamics of an asexually reproducing population crossing a fitness valley, in which individuals of the same evolutionary stage can have variable fitnesses. We find that fitness variation that persists over multiple generations increases the rate of valley crossing through a novel evolutionary mechanism different from previously characterized mechanisms such as stochastic tunneling. By reducing the strength of selection against deleterious intermediates, persistent fitness variation allows for faster adaptation through rugged fitness landscapes.